Impact of genetic testing family screening in hereditary transthyretin amyloidosis

Back

ESC Professional Premium Access

Impact of genetic testing family screening in hereditary transthyretin amyloidosis

Session: Improving diagnosis of cardiac amyloidosis

Topic: Infiltrative Myocardial Disease

Speaker: Doctor N. Mora Ayestaran (Madrid, ES)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Nerea Mora Ayestaran

Hospital Universitario Puerta De Hierro Majadahonda, Madrid (Spain)

0 follower

7 more presentations in this session

Diagnostic prediction model for cardiac amyloidosis due to transthyretin: Insights from the Brazilian multicenter REACT-SP registry

Speaker: Doctor K. Rafael De Paula Morales (Sao Paulo, BR)

Amyloid cardiomyopathy: specificities of transthyretin v30 mutation compared to wild type forms

Speaker: Doctor M. Pereira Santos (Porto, PT)

Misdiagnosis rates in ATTR-CM patients and associated symptoms

Speaker: Mr P. Collins (London, GB)

A systematic review and meta-analysis of diagnostic performance of various echocardiographic parameters in cardiac amyloidosis.

Speaker: Doctor S. Bouloukou (Thessaloniki, GR)

Multiple musculoskeletal procedures and the associated risk of amyloidosis. A Danish nationwide cohort study

Speaker: Doctor N. Noory (Copenhagen, DK)

Access the full session

Improving diagnosis of cardiac amyloidosis

Speakers: Doctor N. Mora Ayestaran, Doctor K. Rafael De Paula Morales, Doctor M. Pereira Santos, Mr P. Collins, Doctor S. Bouloukou...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources